Tachyon Therapeutics jobs and careers
About Tachyon Therapeutics
Tachyon Therapeutics develops novel, selective compounds to improve the treatment of cancer. The company is currently conducting Phase 1 clinical research in patients with advanced cancer to assess the safety, pharmacokinetics, and anti-tumor effectiveness of TACH101. The programs will be advanced in a timely, innovative, high-quality, andscientifically sound manner.
Founded in 2019 by Mike Clarke.
- Founded
- 2019
- Employees
- 1 to 10
- Total funding
- $18.7M
Leadership
The top of Tachyon Therapeutics's org chart, with how many people report into each leader.
Suman Bhattacharya
Sr Vp, Data Science & Development Strategy
3 reports
Isabel Porter
Assist Dir, Planning Administration & Logistics
Rachel Kudgus
Director Of Clinical Pharmacology
Kudgus Lokken
Director Of Clinical Pharmacology
Jobs at Tachyon Therapeutics
No open positions right now. Explore more companies on TheJobsMap.